MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A

The p53 tumor suppressor integrates upstream signals such as DNA damage and active oncogenes to initiate cell cycle arrest or apoptosis. This response is critical to halting inappropriate growth signals. As such, p53 activity is lost in cancer. In melanoma, however, the p53 gene is intact in a repor...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah Alatawi, SoonJye Kho, Michael P. Markey
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/2021/3087579
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546037041987584
author Abdullah Alatawi
SoonJye Kho
Michael P. Markey
author_facet Abdullah Alatawi
SoonJye Kho
Michael P. Markey
author_sort Abdullah Alatawi
collection DOAJ
description The p53 tumor suppressor integrates upstream signals such as DNA damage and active oncogenes to initiate cell cycle arrest or apoptosis. This response is critical to halting inappropriate growth signals. As such, p53 activity is lost in cancer. In melanoma, however, the p53 gene is intact in a reported 94% of human cases. Rather than direct mutation, p53 is held inactive through interaction with inhibitory proteins. Here, we examine the expression of the two primary inhibitors of p53, MDM2 and MDM4, in genomic databases and biopsy specimens. We find that MDM4 is frequently overexpressed. Moreover, changes in splicing of MDM4 occur frequently and early in melanomagenesis. These changes in splicing must be considered in the design of therapeutic inhibitors of the MDM2/4 proteins for melanoma.
format Article
id doaj-art-08f9c05810854cc3a7519dac463f5aae
institution Kabale University
issn 2090-2905
2090-2913
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Skin Cancer
spelling doaj-art-08f9c05810854cc3a7519dac463f5aae2025-02-03T07:24:01ZengWileyJournal of Skin Cancer2090-29052090-29132021-01-01202110.1155/2021/30875793087579MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-AAbdullah Alatawi0SoonJye Kho1Michael P. Markey2Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH 45435, USADepartment of Computer Science and Engineering, Wright State University, Dayton, OH 45435, USADepartment of Biochemistry and Molecular Biology, Wright State University, Dayton, OH 45435, USAThe p53 tumor suppressor integrates upstream signals such as DNA damage and active oncogenes to initiate cell cycle arrest or apoptosis. This response is critical to halting inappropriate growth signals. As such, p53 activity is lost in cancer. In melanoma, however, the p53 gene is intact in a reported 94% of human cases. Rather than direct mutation, p53 is held inactive through interaction with inhibitory proteins. Here, we examine the expression of the two primary inhibitors of p53, MDM2 and MDM4, in genomic databases and biopsy specimens. We find that MDM4 is frequently overexpressed. Moreover, changes in splicing of MDM4 occur frequently and early in melanomagenesis. These changes in splicing must be considered in the design of therapeutic inhibitors of the MDM2/4 proteins for melanoma.http://dx.doi.org/10.1155/2021/3087579
spellingShingle Abdullah Alatawi
SoonJye Kho
Michael P. Markey
MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
Journal of Skin Cancer
title MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
title_full MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
title_fullStr MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
title_full_unstemmed MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
title_short MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
title_sort mdm4 isoform expression in melanoma supports an oncogenic role for mdm4 a
url http://dx.doi.org/10.1155/2021/3087579
work_keys_str_mv AT abdullahalatawi mdm4isoformexpressioninmelanomasupportsanoncogenicroleformdm4a
AT soonjyekho mdm4isoformexpressioninmelanomasupportsanoncogenicroleformdm4a
AT michaelpmarkey mdm4isoformexpressioninmelanomasupportsanoncogenicroleformdm4a